摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[(1RS,2SR)-1-[((3R)-6-chloro-3-[(dimethylamino)methyl]-3,4-dihydro-1(2H)-quinolinyl)carbonyl]-2-(1H-indol-3-yl)propyl]-4-[4-(1H-tetrazol-5-yl)phenoxy]-1-piperidinecarboxamide | 528861-09-8

中文名称
——
中文别名
——
英文名称
N-[(1RS,2SR)-1-[((3R)-6-chloro-3-[(dimethylamino)methyl]-3,4-dihydro-1(2H)-quinolinyl)carbonyl]-2-(1H-indol-3-yl)propyl]-4-[4-(1H-tetrazol-5-yl)phenoxy]-1-piperidinecarboxamide
英文别名
N-[1-[(3R)-6-chloro-3-[(dimethylamino)methyl]-3,4-dihydro-2H-quinolin-1-yl]-3-(1H-indol-3-yl)-1-oxobutan-2-yl]-4-[4-(2H-tetrazol-5-yl)phenoxy]piperidine-1-carboxamide
N-[(1RS,2SR)-1-[((3R)-6-chloro-3-[(dimethylamino)methyl]-3,4-dihydro-1(2H)-quinolinyl)carbonyl]-2-(1H-indol-3-yl)propyl]-4-[4-(1H-tetrazol-5-yl)phenoxy]-1-piperidinecarboxamide化学式
CAS
528861-09-8
化学式
C37H42ClN9O3
mdl
——
分子量
696.252
InChiKey
PTPUDWPNFKVYDL-BEVWLDRHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    50
  • 可旋转键数:
    9
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    135
  • 氢给体数:
    3
  • 氢受体数:
    7

文献信息

  • Amine derivative
    申请人:Abe Hidenori
    公开号:US20050245571A1
    公开(公告)日:2005-11-03
    The present invention provide a compound of the formula: wherein X and X′ are the same or different and each represents a hydrogen atom, etc.; R 1 and R 2 are the same or different and each represents a hydrogen atom, etc.; R 3 represents a hydrocarbon group optionally having substituents, etc.; R 4 represents a hydrogen atom, etc.; Y and Ya are the same or different and each represents a bond or a spacer having a main chain of 1 to 8 atoms; Z and Za are the same or different and each represents a hydrogen atom, etc.; or a salt thereof or a prodrug thereof, having a somatostatin receptor binding inhibitory activity and is useful for preventing and/or treating diseases associated with somatostatin.
    本发明提供一种化合物,其式为:其中X和X′相同或不同,每个代表氢原子等;R1和R2相同或不同,每个代表氢原子等;R3表示一个烃基,可选地具有取代基等;R4表示氢原子等;Y和Ya相同或不同,每个代表键或具有1至8个原子的主链的间隔物;Z和Za相同或不同,每个代表氢原子等;或其盐或前药,具有生长抑素受体结合抑制活性,并用于预防和/或治疗与生长抑素相关的疾病。
  • AMINE DERIVATIVE
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP1437351A1
    公开(公告)日:2004-07-14
    The present invention provide a compound of the formula: wherein X and X' are the same or different and each represents a hydrogen atom, etc.; R1 and R2 are the same or different and each represents a hydrogen atom, etc.; R3 represents a hydrocarbon group optionally having substituents, etc.; R4 represents a hydrogen atom, etc.; Y and Ya are the same or different and each represents a bond or a spacer having a main chain of 1 to 8 atoms; Z and Za are the same or different and each represents a hydrogen atom, etc.; or a salt thereof or a prodrug thereof, having a somatostatin receptor binding inhibitory activity and is useful for preventing and/or treating diseases associated with somatostatin.
    本发明提供一种式的化合物: 其中X和X'相同或不同,各自代表氢原子等;R1和R2相同或不同,各自代表氢原子等;R3代表任选具有取代基的烃基等;R4代表氢原子等。Y和Ya相同或不同,各自代表键或具有1至8个原子的主链的间隔物;Z和Za相同或不同,各自代表氢原子等;或其盐或其原药,具有抑制体生长抑素受体结合的活性,可用于预防和/或治疗与体生长抑素相关的疾病。
查看更多